An interventional study of mask and headset in Primary Headache Disorder, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-06.
Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Treatment
Primary headache can be triggered by light or noise. Getting rest in a quiet and dark environment for the treatment of acute headache is recommended for relief of pain during an attack. It is hard to provide this kind of environment in a busy emergency department. We aimed to determine if eye masks and noise reduction head sets are effective in reducing pain scores, fastening pain relief when used together with standard care. We also aimed to see if these methods were preferred over standard care.
42 studies on the registry are indexed under Headache Disorders, Primary; 13 are open to participants now.
This study's enrollment of 140 is above the median of 50 across 19 interventional studies indexed under Headache Disorders, Primary.
Browse Headache Disorders, Primary studies →Ankara City Hospital Bilkent is the lead sponsor of 443 studies on the registry; 111 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard treatment of primary headache with 10 mg metoclopramide IV in 150 ml saline given over 10 minutes
Other: standard drug
Standard treatment plus eye mask
Other: mask · Other: standard drug
Standard treatment plus headset
Other: headset · Other: standard drug
Standard treatment plus headset plus eye mask
Other: mask · Other: headset · Other: standard drug
investigators will add eye mask to standard treatment
investigators will add headset to standard treatment
investigators will use 10 mg metoclopramide in 150 ml saline given IV over 10 minutes
change in pain
Change in pain measured by visual analogue scale from baseline measurement achieved at min 0. Investigators will use a 100mm visual analogue scale in which 0 represents no pain and 100 mm represents worse pain ever
Time frame: 30 min
change in pain
Change in pain measured by visual analogue scale from baseline measurement achieved at min 0. Investigators will use a 100mm visual analogue scale in which 0 represents no pain and 100 mm represents worse pain ever
Time frame: 60 min
need for rescue analgesic drug
Patients will be asked in one question if they need any additional analgesic or if they are comfortable enough. If a patients wants additional analgesics, regardless of their pain score measured by Visual analogue scale he/she will be given dexketoprofen
Time frame: 60 min
preference of method over standard treatment
Patients will be asked in one question if they will prefer the method of treatment that they received in the study in case they have headache in the future
Time frame: 60 min
Plan to share: No
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara City Hospital Bilkent →